Erste Bank Knock-Out FRE/ AT0000A3EUT4 /
20/12/2024 17:25:00 | Diferencia-0.043 | Bid17:29:24 | Ask17:29:24 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
0.248EUR | -14.78% | - Volumen de oferta: - |
- Tamaño/ Volumen/ Formato de Ask: - |
FRESENIUS SE+CO.KGAA... | 30.6666 - | 31/12/2078 | Call |
GlobeNewswire
24/04
Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for ...
GlobeNewswire
23/04
Transferring Biomedical Research to Patients Faster: ForTra gGmbH Announces Positive Funding Track R...
GlobeNewswire
23/02
Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatm...
GlobeNewswire
04/09/2023
CIO Leadership: Generative AI and Visionary Leadership in the Enterprise Will Power the Discussion a...
GlobeNewswire
31/08/2023
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página